Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Dehydrogenase
    (2)
  • Others
    (2)
Filter
Search Result
Results for "

idh1r132c

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
IDH1 Inhibitor 1
T116132234285-81-3
IDH1 Inhibitor 1 is an orally bioavailable, brain-penetrant, and selective mutant IDH1 inhibitor (IC50s: 0.021 μM, 0.045 μM, and 2.52 μM for IDH1R132H, IDH1R132C, and IDH1WT).
  • Inquiry Price
10-14 weeks
Size
QTY
IDH-305
T155501628805-46-8
IDH-305 is an orally available, mutation-selective, and brain-penetrant IDH1 inhibitor targeting the IDH1 (R132) mutation. It is 200-fold more selective for mutant IDH1 isoforms than wild type, with IC50s of 27 nM, 28 nM, and 6.14 nM for IDH1R132H, IDH1R132C, and IDH1WT, respectively.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
IDH889
T155511429179-07-6
IDH889 is a brain penetrant, an allosteric and mutant specific IDH1 inhibitor. IDH889 has effective selectivity for IDH1 R132* mutations (IC50s: 0.02 μM, 0.072 μM, and 1.38 μM for IDH1R132H, IDH1R132C, and IDH1wt).
  • Inquiry Price
6-8 weeks
Size
QTY
Safusidenib
T637781898206-17-1
Safusidenib is a selective, orally active mutant inhibitor of IDH1 that significantly inhibits mutant IDH1, but not wild-type IDH1, and inhibits tumor activity in chondrosarcoma. safusidenib is active against IDH1R132H and IDH1R132C, and in the absence of preincubation, the IC50 values were 15 and 130 nM, respectively.
  • Inquiry Price
6-8 weeks
Size
QTY